Literature DB >> 25266618

Neonatal citrullinemia: novel, reversible neuroimaging findings correlated with ammonia level changes.

John Ruder1, Joseph Legacy2, George Russo3, Ronald Davis3.   

Abstract

BACKGROUND: Citrullinemia type I is an autosomal recessive disorder of the urea cycle in which a patient lacks the cytosolic enzyme, argininosuccinic acid synthetase. This enzyme deficiency results in elevated levels of ammonia, glutamine, and citrulline. The accumulation of ammonia and glutamine causes neurodegenerative changes that are detectible on magnetic resonance imaging. This is the first case report of citrullinemia with repeat magnetic resonance images and electroencephalographs in the acute phase of hyperammonemia. CASE: This 3800 g white boy was born at 40 weeks 4 days gestation to a 25-year-old mother. He was delivered at home to a certified midwife with no reported complications. He was doing well until day of life 4, when the mother reported he would no longer latch to feed. He was observed to have markedly elevated ammonia levels and ultimately diagnosed with citrullinemia type I. The initial magnetic resonance image was markedly abnormal. After aggressive medical management, his repeat magnetic resonance image revealed marked improvement in the acute setting.
CONCLUSION: Early and aggressive management of hyperammonemia can result in improved magnetic resonance imaging findings in the acute setting. It is too early to know if this will translate to an improved clinical outcome. Clinical suspicion must remain high for urea cycle disorders in neonates with magnetic resonance image changes similar to those resulting from hypoxic-ischemic injury.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ammonia; citrullinemia; neonate; urea cycle disorder

Mesh:

Year:  2014        PMID: 25266618     DOI: 10.1016/j.pediatrneurol.2014.07.010

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

1.  Protective effect of resveratrol on citrullinemia type I-induced brain oxidative damage in male rats.

Authors:  Larissa Delmonego; Thayná Patachini Maia; Débora Delwing-Dal Magro; Karine Louize Vincenzi; Aline Barbosa Lima; Luana Carla Pscheidt; Letícia Eger; Daniela Delwing-de Lima
Journal:  Metab Brain Dis       Date:  2021-02-08       Impact factor: 3.584

2.  Effects of resveratrol on alterations in cerebrum energy metabolism caused by metabolites accumulated in type I citrullinemia in rats.

Authors:  Karine Louize Vincenzi; Thayna Patachini Maia; Larissa Delmônego; Aline Barbosa Lima; Luana Carla Pscheidt; Débora Delwing-Dal Magro; Daniela Delwing-de Lima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-18       Impact factor: 3.000

Review 3.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

4.  Effects of potassium adsorption filters on the removal of ammonia from blood products.

Authors:  Hiroshi Fujita; Yoko Shiotani; Yuko Takada; Shigeko Nishimura
Journal:  Blood Transfus       Date:  2017-03-01       Impact factor: 3.443

5.  Newborn metabolic vulnerability profile identifies preterm infants at risk for mortality and morbidity.

Authors:  Scott P Oltman; Elizabeth E Rogers; Rebecca J Baer; Elizabeth A Jasper; James G Anderson; Martina A Steurer; Matthew S Pantell; Mark A Petersen; J Colin Partridge; Deborah Karasek; Kharah M Ross; Sky K Feuer; Linda S Franck; Larry Rand; John M Dagle; Kelli K Ryckman; Laura L Jelliffe-Pawlowski
Journal:  Pediatr Res       Date:  2020-10-01       Impact factor: 3.756

6.  Citrullinemia with an Atypical Presentation: Paroxysmal Hypoventilation Attacks.

Authors:  Zeynep Öztürk; Tuğba Hirfanoğlu; Aslı İnci; İlyas Okur; Esin Koç; Leyla Tümer; Ebru Arhan; Kürşad Aydın; Ayşe Serdaroğlu
Journal:  J Pediatr Neurosci       Date:  2018 Apr-Jun

7.  Citrullinemia type I in Chinese children: Identification of two novel argininosuccinate synthetase gene mutations.

Authors:  Mei Xiong; Mingwu Chen
Journal:  Front Pediatr       Date:  2022-10-03       Impact factor: 3.569

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.